Roivant Sciences Ltd. held its 2024 Annual General Meeting where shareholders approved four proposals, including the re-election of directors and the appointment of Ernst & Young as auditors for the fiscal year 2025, with a total of 680,116,302 shares present out of 739,183,842 outstanding.